Soho Flordis International (SFI) is a global natural medicine company committed to identifying and developing natural medicines with the best evidence of effectiveness, quality and safety, and marketing them around the world.

SFI is focused on bringing its products to market through healthcare professionals with the endorsement of world class opinion leaders.


SFI is committed to ensuring that people globally have access to quality, innovative evidence based natural medicines. Therefore it is our aim that the safety and efficacy claims for our products are supported by clinical studies conducted on the exact finished products. This higher standard enables the selection of safe, appropriate and effective treatments.
View our brands here.

International Community of Experts

SFI is building an international community of leading herbal and medical companies, experts, scientists and researchers.
View our partners here.

Commitment to Research

We are committed to further developing the evidence for our products.
View our research programs here.


latest news

  • KeenMind features in Nutraceuticals World
    20 October 2014 15:36

    KeenMind features in Nutraceuticals World October 2014 highlighting the numerous randomised, double-blind, placebo-controlled studies that make KeenMind a leader in evidence-based supplementation for cognitive maintenance and improvement.

  • Ginsana at Vitafoods, presenting the new SFI Group
    21 May 2014 00:00

    Vitafoods Europe 2014 lived up to its reputation as the most crucial event for the European healthy foods and nutraceuticals sector. Ginsana was there and presented itself for the first time on such an occasion as part of the new SFI Group.

  • Award for SFI - Healthcare Deal of the Year, Asia Pacific
    12 March 2014 13:29

    SFI has have been selected as "Healthcare Deal of the Year, Asia Pacific” for our acquisitions of Ginsana and ProThera.

  • SFI Products Launch in Korea
    10 March 2014 10:00

    Ginsana SA is particularly proud to announce and celebrate the Korean launch of three of its best selling medicinal products as the first in Asia since having joined the family of Soho Flordis International (SFI).

  • Announcement - Acquisition of the US Company "Complementary Prescriptions"
    25 February 2014 09:00

    Soho Flordis International (SFI), announced today the acquisition of Complementary Prescriptions LLC (CP), a leading nutraceutical company based in Carson City, Nevada (USA).